Fatty liver disease

The email wasn’t unexpected. Earlier in the week, I had received a call from my transplant coordinator at one of the two hospitals where I’m…

A once-monthly investigational therapy for metabolic dysfunction-associated steatohepatitis (MASH), called efimosfermin, has earned two new regulatory designations — one in the U.S. and the other…

One of the things I’ve been most grateful for over the past few years is simple: I’m not as sick as I once was. When…

Clearing senescent macrophages, a type of damaged immune cell that doesn’t die off as it should, reduced inflammation and reversed signs of liver fat buildup…

As much as I’d like to believe the tough people who say they have “no regrets,” I’m not buying it. You mean to…

A Phase 2 clinical trial testing Rivus Pharmaceuticals‘ experimental oral therapy HU6 in people with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of…

April 19 marks World Liver Day, a global effort to raise awareness about liver health and the growing burden of liver disease. This year’s…

David Frank, who lost his mother to a severe form of steatotic liver disease and has since become a strong liver health advocate, is…

April is officially recognized in the U.S. as National Donate Life Month, an opportunity to highlight the extraordinary impact of organ donation, and the…

Some of my least-favorite calls to make are to cancel doctor appointments. Maybe it’s the Jenga-like way I have to wedge them into my life.